Prescription of generic drugs in general practice. Results of a survey of general practitioners;Verordnung von generika in der hausärztlichen praxis: Ergebnisse einer befragung von hausärzten

Medizinische Klinik

Volumn 101, Issue 9, 2006, Pages 705-710

  Simmenroth Nayda, Anne ^a   Hummers Pradier, Eva ^b   Ledig, Thomas ^c   Jansen, Rolf ^c   Niebling, Wilhelm ^d   Bjerre, Lise M ^a   Kochen, Michael M ^a   Himmel, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Hausärztliche Gemeinschaftspraxis Ditzingen ^*  (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Attitude of health personnel; Family physician; Family practice; Generic prescribing; Interprofessional relations

Indexed keywords

GENERIC DRUG;

ATTITUDE; EXPERIENCE; GENERAL PRACTICE; GENERAL PRACTITIONER; GERMANY; HEALTH SURVEY; HOSPITAL; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; REVIEW;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; DRUG COSTS; DRUG PRESCRIPTIONS; DRUGS, GENERIC; FAMILY PRACTICE; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 33748951576     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1097-6     Document Type: Review

References (30)

1. Becker-Brüser W. Gesundheitsreform behindert rationale Therapie. Z Allgemeinmed 2004;80:23-5.
2. Dietrich S, Hansen H. Therapiehoheit bleibt beim Arzt. Dtsch Ärztebl 2002;99:1576-7.
3. Schwabe U, Paffrath D, Hrsg. Arzneiverordnungs-Report 2004. Berlin-Heidelberg-New York: Springer, 2005:13-6, 156-9.
4. Schwabe U, Paffrath D, Hrsg. Arzneiverordnungs-Report 2005. Berlin-Heidelberg-New York: Springer, 2006:4-19, 191-242.
5. Lagarce L, Lusson-Brisst C, Bruhat C, et al. How practitioners view generic drugs: an opinion study from general practitioners in Maine-et-Loire. Therapie 2005;60:67-74.
6. Avery AJ, Wetzels RV, Rodgers S, et al. Do GP's working in practice with high or low prescribing costs have different views on prescribing issues? Br J Gen Pract 2000;50:100-4.
7. Watkins C, Harvey I, Carthy P, et al. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care 2003;12:29-34.
8. Dowell JS, Snadden D, Dunbar JA. Changing generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995;310:505-8.
9. Haas JS, Philips KA, Gerstenberger MS, et al. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey. Ann Intern Med 2005;142:891-7.
10. Ashworth M, Armstrong D, Colwill S, et al. Motivating general practitioners to change their prescribing: the incentive of working together. J Clin Pharm Ther 2000;25:119-24.
11. Avery AJ, Rodgers S, Heron T, et al. A prescription for improvement? An observational study to identify how general practitioners vary in their growth in prescription costs. BMJ 2000;321:276-81.
12. Himmel W, Simmenroth-Nayda A, Niebling W, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2004;43:472-9.
13. SAS Institute. SAS STAT user's guide, 3 vol, version 8. Cary: SAS Institute, 1999.
14. Wetzel D, Himmel W, Heidenreich R, et al. Participation in a quality of care study and consequences for generalizability of general practice research. Fam Pract 2005;22:458-64.
15. Schwabe U, Paffrath D, Hrsg. Arzneiverordnungs-Report 2001. Berlin-Heidelberg-New York: Springer, 2001:730-4.
16. Devulder J, De Laat M, Dumoulin K, et al. Palliative care: knowledge and attitudes of general practitioners. Acta Clin Belg 1997;52:207-10.
17. Denig P, Rethans JJ. Inconsistent prescribing behaviour by physicians. Eur J Gen Pract 1996;2:153-6.
18. Carthy P, Harvey I, Brawn R, et al. A study of factors associated with cost and variation in prescription among GP's. Fam Pract 2000;17:36-41.
19. Hellerstein J. The importance of the physician in the generic versus trade-name prescription decision. J Econ 1998;29:108-36.
20. Banahan BF. A physician survey on generic drugs and substitution. Arch Intern Med 1997;157:2080-8.
21. Gleiter CH, Klotz U, Kuhlmann J, et al. When are bioavailability studies required? A German proposal. J Clin Pharmacol 1998;38:904-11.
22. Petersen KU. Originale und Nachahmer. Med Klin 2000;95:26-30.
23. Krämer G, Schnebel H, Wolf P. Risiken der neuen Aut-idem Regelung für die Behandlung mit Antiepileptika. Akt Neurol 2002;29:115-22.
24. Barsky AJ, Saintforth R, Rogers MP, et al. Non-specific medication side effects and the nocebo phenomen. JAMA 2002;287:622-7.
25. Fyock J, Stangor C. The role of memory biases in stereotype maintenance. Br J Soc Psychol 1994;33:331-43.
26. Simmenroth-Nayda A, Hummers-Pradier E, Bjerre LM, et al. Umstellung von Originalpräparate auf Generika - eine Pilotstudie. Z Allgemeinmed 2000;76:Kongress-Abstracts:57.
27. Shrank WH, Hoang T, Ettner SL, et al. Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006;166:332-7.
28. Bijl D, Van Sonderer E, Haaijer-Ruskamp FM. Prescription changes and drug costs at the interface between primary and specialist care. Eur J Clin Pharmacol 1998;54:33-6.
29. Himmel W, Kochen, MM, Sorns U, et al. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther 2004;42:103-9.
30. Glaeske G, Janhsen K. GEK-Arzneimittel-Report 2006. Schriftenreihe zur Gesundheitsanalyse, Bd 44. St. Augustin: Asgard, 2006.